Mv-4-11 Cells
Mv-4-11 Cells - Related Videos
01:56
Inducing Paralysis in a Mouse Model via Transfer of Aquaporin-4-Specific Th17 Cells
0 Views •
2025
This video demonstrates the procedure of inducing paralysis by transferring activated Th17 cells targeting aquaporin-4 into a mouse model. In the central nervous system, the activated Th17 cells interact with aquaporin-4-expressing astrocytes, triggering an immune response that leads to tail and limb paralysis in the mouse.
09:36
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures
0 Views •
Cited by 8 •
2016
Here, we present an overview of the preparation and animal handling procedures required to safely perform medical imaging in an animal biosafety level 4 laboratory. Computed tomography of a mock-infected guinea pig illustrates these procedures that may be used to evaluate the disease caused by a high consequence pathogen.
10:31
Universal Molecular Retention with 11-Fold Expansion Microscopy
0 Views •
2023
Presented here is a new version of expansion microscopy (ExM), Magnify, that is modified for up to 11-fold expansion, conserving a comprehensive array of biomolecule classes, and is compatible with a broad range of tissue types. It enables the interrogation of the nanoscale configuration of biomolecules using conventional diffraction-limited microscopes.
![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg%3Fv%3D2026-09-01%252015%253A47%253A42&w=750&q=75)
07:12
Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions
0 Views •
2020
New routes for the synthesis of nitrogen-containing heterocycles utilizing cercosporin as a metal-free photocatalyst were developed.
01:23
Dipeptidyl Peptidase 4 Inhibitors
0 Views •
2024
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
FAQs
The KMT2A-AFF1 fusion and FLT3 internal tandem duplication contribute through different but complementary routes. The fusion is associated with abnormal transcription, whereas the FLT3 alteration promotes kinase signaling. Together, these oncogenic drivers support the abnormal proliferation and survival examined in MV4-11 cells, allowing researchers to connect defined molecular changes with leukemia-relevant cellular behavior.
FLT3-targeted inhibitors are valuable in this model because the cells carry an internal tandem duplication in FLT3, a molecular feature linked to kinase signaling, proliferation, and survival. Testing these inhibitors in MV4-11 cells helps researchers assess therapeutic response in a genetically defined setting and investigate why sensitivity may give way to drug resistance.
Genetic definition improves interpretation of treatment experiments. Because the relevant KMT2A-AFF1 and FLT3 alterations are known, a change after treatment can be examined in relation to specific oncogenic drivers rather than an unspecified leukemia background. This makes MV4-11 cells useful for mechanistic studies that connect molecular alterations to anticancer response.
Researchers apply MV4-11 cells to leukemia biology, inhibitor testing, and combination-treatment studies. Their reproducible growth provides a consistent experimental system for comparing how anticancer strategies affect cells carrying the same defined drivers. The model therefore supports early evaluation of treatment concepts before researchers test whether the findings extend to primary cells or animal models.
Combination studies can be used to evaluate how multiple anticancer strategies act together and whether treatment responses are accompanied by resistance-related behavior. In MV4-11 cells, this work is especially relevant when one component addresses FLT3-associated signaling while the broader experiment examines how genetically driven proliferation and survival respond to coordinated intervention.
Results from MV4-11 experiments represent an intermediate research step rather than a complete prediction of treatment performance. The cell line enables reproducible, genetically focused testing, but the model is intended to precede validation in primary cells or animal models. Follow-up studies help determine whether observed responses and resistance mechanisms extend beyond this cellular system.